Navigation Links
Two Former Covance Senior Executives Join MedAvante Board of Directors

HAMILTON, N.J., June 21, 2016 /PRNewswire/ -- MedAvante, Inc., the leader in technology-based clinical trial services for central nervous system (CNS) diseases, announced two new members of its Board of Directors: Richard F. Cimino, former Covance, Inc. EVP and Group President of Clinical Development and Commercialization Services, and Nigel Brown, former Corporate Vice President of Business Development and Strategy at Covance.

Mr. Cimino and Dr. Brown join MedAvante at a critical time as the company continues to expand both its global presence and the range of therapeutic areas in which its Virgil® Investigative Study Platform powers clinical trials. As former Covance leadership team executives and Contract Research Organization (CRO) veterans, their experience, clinical knowledge and strategic acumen will be critical as MedAvante consolidates its position as the leader in electronic source data (eSource).

"As the experienced pioneer in eSource data, MedAvante is on the leading edge of a clear transition in pharmaceutical clinical trials – the shift from paper-based trials to digital," said MedAvante CEO Paul Gilbert. "Rick and Nigel both possess the experience as well as the strategic vision to recognize the enormous advantages drug developers gain through smarter, faster clinical trials. They will make significant and substantive contributions to MedAvante's growth as we reduce the time and cost companies require to get vital drugs to the patients who need them."

Mr. Cimino brings a wealth of experience in global clinical pharmacology, early clinical development, and Phase II-IV clinical development as well as in business development and strategic marketing. He served 11 years on the Covance Executive Committee, through 2015. Prior to this, Mr. Cimino worked for 20 years at Eastman Kodak, where he was instrumental in the digital transformation of Kodak's second-largest business, now Carestream Health Inc. He also acted as an independent director for BioClinica from 2005-2011.

Dr. Brown is the current CEO of Princeton Healthcare Advisory LLC. Dr. Brown served for a decade as a member of the Executive Committee at Covance until 2015, where his responsibilities included M&A as well as licensing and strategic partnership deals. Before joining MedAvante's Board, Brown served the company as a senior adviser, providing counsel on its continuing improvements of electronic clinical outcome assessment (eCOA) administration in CNS studies. His contributions have helped improve the digital data capture functionality of the Virgil Investigative Study Platform.

About MedAvante:

MedAvante is the global clinical data services company dedicated to maximizing signal detection in clinical trials. Founded in 2002, MedAvante pioneered Central Ratings, a groundbreaking clinical trial methodology. This heritage of clinical expertise, coupled with technical innovation and operational skills, enabled MedAvante to develop the electronic source (eSource) platform, Virgil, the first such technology to replace costly and error-prone paper rating scales with real-time digital collection and cloud management of source data. Designed by clinicians for clinicians, Virgil offers built-in clinical guidance to ensure accurate, standardized assessments. MedAvante helps brings better drug therapies to market through smarter, faster clinical trials. Based in Hamilton, NJ with operations teams in the US, Germany, Russia and Japan, MedAvante delivers services for clinical trials in more than 40 countries worldwide. For more information, please visit


To view the original version on PR Newswire, visit:

SOURCE MedAvante, Inc.
Copyright©2016 PR Newswire.
All rights reserved

Related medicine technology :

1. North American Cannabis Holdings and Former Chicago Bears QB Jim McMahon Announce The Cannabis Sports Policy Project
2. Paul Mirabella, former GE Healthcare Officer, Joins ControlRad Systems Board of Directors
3. Larry Klayman files lawsuit against Former FDA commissioner Hamburg, Johnson & Johnson and others sued for alleged racketeering and other claims over dangerous drug Levaquin
4. Spero Therapeutics Hires Former Biomedical Advanced Research and Development Authority (BARDA) Anti-Infectives Program Chief
5. BAXALTA INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Baxalta Incorporated
6. Conavi Medical (formerly Colibri Technologies) announces FDA 510k clearance for its first product, the Foresight ICE System for Intracardiac Echocardiography
7. Former Philips Health Systems Corporate VP and Head of North American Business Transformation Joins Respiratory Motion as Chief Commercial Officer
8. John Boehner, Former Speaker of the House to Deliver Keynote at MHA 2016 Business Summit
9. Respiratory Motion Welcomes Former Siemens Health Services Executive as Head of Business Development
10. Freedom Scientific et Optelec unissent leurs forces pour former une alliance dans le domaine des technologies dassistance
11. RC21X Provides Lifetime Brain Performance Monitoring to Former NFL Players
Post Your Comments:
(Date:12/6/2019)... ... December 06, 2019 , ... Nobilis Therapeutics , a ... disorders, announced today that the U.S. Food and Drug Administration (FDA) has cleared ... initiate its Phase 2b trial for the treatment of patients with Posttraumatic Stress ...
(Date:12/6/2019)... ... December 06, 2019 , ... ... Forbidden Fruit Garden Supply LLC (a division of Horticultural Holdings LLC) to recommend ... professional growers. , FFGS is a team of disciplined and energetic plant ...
(Date:12/5/2019)... ... December 05, 2019 , ... nView, a leading ... to the role of Chief Product Officer. As the company expands its portfolio ... of the behavioral health market into nView’s product and company growth strategy. Rosenbaum ...
Breaking Medicine Technology:
(Date:12/14/2019)... , ... December 13, 2019 , ... ... planning, has announced the Top 15 Master's in Child Development Degree Programs for ... colleges and universities in the nation. Each program is evaluated based on curriculum ...
(Date:12/9/2019)... ... December 09, 2019 , ... Greenlight Guru, quality management ... platform’s - - Change Management capabilities . The enhanced Change Management capabilities ... items impacted by change orders in a collaborative change workspace, while also ensuring ...
(Date:12/8/2019)... ... December 07, 2019 , ..., a trusted resource for ... Master of Science in Nursing (MSN) Degree Programs for 2020. The comprehensive research ... the nation. Each program is evaluated based on curriculum quality, graduation rate, reputation, ...
(Date:12/6/2019)... ... December 06, 2019 , ... Connecticut is home ... excellence in patient care. On December 12th, Hartford Business Journal will recognize eight ... Care Heroes Awards at the Hartford Marriott. , “We are fortunate to have ...
(Date:12/6/2019)... ... 06, 2019 , ... Brain Sentinel, Inc. announces it is ... AES Annual Meeting. The symposium, “Fundamentals of Quantitative Surface Electromyography (sEMG) for Long-Term ... analysis during ictal events;, 2. Review specific sEMG patterns of motor seizures and ...
Breaking Medicine News(10 mins):